Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Free Cash Flow: 2021-2025

Historic Free Cash Flow for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to -$2.4 million.

  • MDxHealth's Free Cash Flow rose 59.55% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.8 million, marking a year-over-year increase of 43.40%. This contributed to the annual value of -$25.9 million for FY2024, which is 13.85% up from last year.
  • Latest data reveals that MDxHealth reported Free Cash Flow of -$2.4 million as of Q3 2025, which was down 53.29% from -$1.6 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Free Cash Flow ranged from a high of $17.9 million in Q2 2022 and a low of -$18.9 million during Q3 2021.
  • Its 3-year average for Free Cash Flow is -$5.1 million, with a median of -$5.9 million in 2024.
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 249.17% in 2022, then dropped by 28.96% in 2024.
  • Over the past 5 years, MDxHealth's Free Cash Flow (MRQ) stood at -$18.9 million in 2021, then soared by 52.76% to -$8.9 million in 2022, then rose by 29.52% to -$6.3 million in 2023, then fell by 7.71% to -$6.8 million in 2024, then soared by 64.97% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q3 2025, -$1.6 million for Q2 2025, and -$4.1 million during Q1 2025.